{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:02:41Z","timestamp":1787796161852,"version":"build-2784847793"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,27]],"date-time":"2025-07-27T00:00:00Z","timestamp":1753574400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Medical Sciences"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.advms.2025.07.001","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T15:16:06Z","timestamp":1753283766000},"page":"291-300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of anti-HLA antibodies on the immunological status of patients with cardiac allograft vasculopathy (CAV) after heart transplantation"],"prefix":"10.1016","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3956-4914","authenticated-orcid":false,"given":"Katarzyna","family":"Kowalik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4904-6398","authenticated-orcid":false,"given":"Joanna","family":"Was","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Kozar-Kaminska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3106-5427","authenticated-orcid":false,"given":"Ilona","family":"Minota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4114-1374","authenticated-orcid":false,"given":"Krzysztof","family":"Komuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneta","family":"Rekawek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9277-0552","authenticated-orcid":false,"given":"Tomasz","family":"Zielinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.advms.2025.07.001_bib1","series-title":"StatPearls","article-title":"Heart transplantation allograft vasculopathy. 2023 May 22","author":"Shetty","year":"2025"},{"key":"10.1016\/j.advms.2025.07.001_bib2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/164_2021_547","article-title":"Adverse effects of immunosuppression: nephrotoxicity, hypertension, and metabolic disease","volume":"272","author":"Hoosain","year":"2022","journal-title":"Handb Exp Pharmacol"},{"issue":"4","key":"10.1016\/j.advms.2025.07.001_bib3","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.surg.2018.05.056","article-title":"Postrenal transplant infection: what is the effect of specific immunosuppressant agents?","volume":"164","author":"Monlezun","year":"2018","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.advms.2025.07.001_bib4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cll.2018.10.006","article-title":"Signaling molecules in posttransplantation cancer","volume":"39","author":"Balan","year":"2019","journal-title":"Clin Lab Med"},{"issue":"5","key":"10.1016\/j.advms.2025.07.001_bib5","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/CIRCULATIONAHA.117.028533","article-title":"Chronic rejection of cardiac allografts is associated with increased lymphatic flow and cellular trafficking","volume":"137","author":"Edwards","year":"2018","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.advms.2025.07.001_bib6","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3325\/cmj.2014.55.562","article-title":"Cardiac allograft vasculopathy: diagnosis, therapy, and prognosis","volume":"55","author":"Skori\u0107","year":"2014","journal-title":"Croat Med J"},{"issue":"8","key":"10.1016\/j.advms.2025.07.001_bib7","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.healun.2010.05.034","article-title":"The international society of heart and lung transplantation guidelines for the care of heart transplant recipients","volume":"29","author":"Costanzo","year":"2010","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"10.1016\/j.advms.2025.07.001_bib8","first-page":"48","article-title":"Is cytoimmunological monitoring a safe follow-up method for heart transplantation patients?","volume":"11","author":"Cingoz","year":"2014","journal-title":"Kardiochir Torakochirurgia Pol"},{"issue":"12","key":"10.1016\/j.advms.2025.07.001_bib9","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.healun.2013.08.011","article-title":"The 2013 international society for heart and lung transplantation working formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation","volume":"32","author":"Berry","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.advms.2025.07.001_bib10","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.healun.2005.03.019","article-title":"Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection","volume":"24","author":"Stewart","year":"2005","journal-title":"J Heart Lung Transplant"},{"issue":"3 Pt 2","key":"10.1016\/j.advms.2025.07.001_bib11","first-page":"S124","article-title":"Transplant coronary disease: nonimmunologic risk factors","volume":"11","author":"Johnson","year":"1992","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"10.1016\/j.advms.2025.07.001_bib12","first-page":"229","article-title":"Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant","volume":"6","author":"Kaczmarek","year":"2008","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.advms.2025.07.001_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-62703-493-7_2","article-title":"Antibodies in transplantation: the effects of HLA and non-HLA antibody binding and mechanisms of injury","volume":"1034","author":"Valenzuela","year":"2013","journal-title":"Methods Mol Biol"},{"issue":"12","key":"10.1016\/j.advms.2025.07.001_bib14","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14483","article-title":"The effects of donor-specific antibody characteristics on cardiac allograft vasculopathy","volume":"35","author":"Wang","year":"2021","journal-title":"Clin Transplant"},{"key":"10.1016\/j.advms.2025.07.001_bib15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jaut.2018.11.006","article-title":"Germinal center humoral autoimmunity independently mediates progression of allograft vasculopathy","volume":"98","author":"Qureshi","year":"2019","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.advms.2025.07.001_bib16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/MOT.0000000000000591","article-title":"Effector B cells in cardiac allograft vasculopathy","volume":"24","author":"Zorn","year":"2019","journal-title":"Curr Opin Organ Transplant"},{"issue":"2","key":"10.1016\/j.advms.2025.07.001_bib17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/TP.0b013e3181e25a59","article-title":"Humoral autoimmunity and transplant vasculopathy: when allo is not enough","volume":"90","author":"Win","year":"2010","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.advms.2025.07.001_bib18","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/MOT.0000000000000559","article-title":"Regulatory B cells and transplantation: almost prime time?","volume":"23","author":"Mohib","year":"2018","journal-title":"Curr Opin Organ Transplant"},{"issue":"1","key":"10.1016\/j.advms.2025.07.001_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.immuni.2013.01.004","article-title":"Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy","volume":"38","author":"Liao","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.advms.2025.07.001_bib20","series-title":"Immunologia. Wydanie 8","author":"Golab","year":"2023"},{"issue":"4\u20135","key":"10.1016\/j.advms.2025.07.001_bib21","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.clinbiochem.2016.01.004","article-title":"Cytokine-based immune monitoring","volume":"49","author":"Mill\u00e1n","year":"2016","journal-title":"Clin Biochem"},{"issue":"1","key":"10.1016\/j.advms.2025.07.001_bib22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.anndiagpath.2012.08.002","article-title":"Distinct expression of interleukin 17, tumor necrosis factor \u03b1, transforming growth factor \u03b2, and forkhead box P3 in acute rejection after kidney transplantation","volume":"17","author":"de Menezes Neves","year":"2013","journal-title":"Ann Diagn Pathol"},{"issue":"Suppl 1","key":"10.1016\/j.advms.2025.07.001_bib23","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1097\/FTD.0000000000000253","article-title":"T-Cell cytokines as predictive markers of the risk of allograft rejection","volume":"38","author":"Brunet","year":"2016","journal-title":"Ther Drug Monit"},{"issue":"17\u201318","key":"10.1016\/j.advms.2025.07.001_bib24","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.cca.2012.04.014","article-title":"Cytokines as predictive biomarkers of alloreactivity","volume":"413","author":"Brunet","year":"2012","journal-title":"Clin Chim Acta"},{"issue":"1","key":"10.1016\/j.advms.2025.07.001_bib25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00007691-200302000-00003","article-title":"Quantification of immunosuppression by flow cytometry in stable renal transplant recipients","volume":"25","author":"Stalder","year":"2003","journal-title":"Ther Drug Monit"},{"issue":"5","key":"10.1016\/j.advms.2025.07.001_bib26","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1073\/pnas.041608298","article-title":"Requirement for natural killer T (NKT) cells in the induction of allograft tolerance","volume":"98","author":"Seino","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.advms.2025.07.001_bib27","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1146\/annurev.immunol.23.021704.115742","article-title":"Toward an understanding of NKT cell biology: progress and paradoxes","volume":"23","author":"Kronenberg","year":"2005","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"10.1016\/j.advms.2025.07.001_bib28","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1189\/jlb.1106654","article-title":"Reduced CD4+ subset and Th1 bias of the human iNKT cells in type 1 diabetes mellitus","volume":"81","author":"Kis","year":"2007","journal-title":"J Leukoc Biol"},{"issue":"2","key":"10.1016\/j.advms.2025.07.001_bib29","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/clim.2001.5060","article-title":"Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage","volume":"100","author":"van der Vliet","year":"2001","journal-title":"Clin Immunol"},{"issue":"1","key":"10.1016\/j.advms.2025.07.001_bib30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1365-2249.1999.01018.x","article-title":"Natural killer (NK) T cells are significantly decreased in the peripheral blood of patients with rheumatoid arthritis (RA)","volume":"118","author":"Yanagihara","year":"1999","journal-title":"Clin Exp Immunol"},{"issue":"11","key":"10.1016\/j.advms.2025.07.001_bib31","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1002\/eji.201040619","article-title":"Invariant natural killer T cells: linking inflammation and neovascularization in human atherosclerosis","volume":"40","author":"Kyriakakis","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.advms.2025.07.001_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ebiom.2016.08.044","article-title":"Can circulating regulatory T cells predict cardiovascular disease?","volume":"11","author":"Bj\u00f6rkbacka","year":"2016","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.advms.2025.07.001_bib33","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00019501-200609000-00005","article-title":"Lower prevalence of circulating natural killer T cells in patients with angina: a potential novel marker for coronary artery disease","volume":"17","author":"Andoh","year":"2006","journal-title":"Coron Artery Dis"},{"issue":"18","key":"10.1016\/j.advms.2025.07.001_bib34","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.1182\/blood-2008-06-165506","article-title":"Host natural killer T cells induce an interleukin-4-dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host disease","volume":"113","author":"Pillai","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.advms.2025.07.001_bib35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.healun.2015.08.008","article-title":"Donor-specific HLA alloantibodies: impact on cardiac allograft vasculopathy, rejection, and survival after pediatric heart transplantation","volume":"35","author":"Tran","year":"2016","journal-title":"J Heart Lung Transplant"},{"issue":"2","key":"10.1016\/j.advms.2025.07.001_bib36","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.healun.2005.09.003","article-title":"Acute antibody-mediated rejection of cardiac transplants","volume":"25","author":"Reed","year":"2006","journal-title":"J Heart Lung Transplant"},{"issue":"2","key":"10.1016\/j.advms.2025.07.001_bib37","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1600-6143.2010.03383.x","article-title":"De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival","volume":"11","author":"Smith","year":"2011","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.advms.2025.07.001_bib38","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.transproceed.2007.01.083","article-title":"No evidence for an improvement of long-term survival by HLA matching in heart transplant recipients","volume":"39","author":"Tenderich","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.advms.2025.07.001_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2022.101706","article-title":"Significance of HLA-matching and anti-HLA antibodies in heart transplant patients receiving induction therapy?","volume":"75","author":"Gavroy","year":"2022","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.advms.2025.07.001_bib40","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev-immunol-041015-055605","article-title":"Follicular helper T cells","volume":"34","author":"Vinuesa","year":"2016","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"10.1016\/j.advms.2025.07.001_bib41","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1038\/s41598-018-22391-w","article-title":"Allogeneic dendritic cells stimulated with antibodies against HLA class II polarize naive T cells in a follicular helper phenotype","volume":"8","author":"D\u00e9sy","year":"2018","journal-title":"Sci Rep"}],"container-title":["Advances in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S189611262500029X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S189611262500029X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T16:16:52Z","timestamp":1764605812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S189611262500029X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S189611262500029X"],"URL":"https:\/\/doi.org\/10.1016\/j.advms.2025.07.001","relation":{},"ISSN":["1896-1126"],"issn-type":[{"value":"1896-1126","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of anti-HLA antibodies on the immunological status of patients with cardiac allograft vasculopathy (CAV) after heart transplantation","name":"articletitle","label":"Article Title"},{"value":"Advances in Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.advms.2025.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Medical University of Bialystok.","name":"copyright","label":"Copyright"}]}}